Susceptibility of Aminoglycoside Resistant <i> Acinetobacter baumannii </i> to Antibiotic Combinations

In Vitro Antimicrobial Combinations for Pan-Drug Resistant Acinetobacter Species

Evaluation of potential synergistic activity of antimicrobial combinations against Colistin resistant Acinetobacter baumannii

In vitro comparison of colistin- versus tigecycline-based combinations against carbapenem resistant Acinetobacter baumannii intensive care unit clinical isolates

Testing of antibiotic combinations in <i>NDM-1-</i>producing nosocomial carbapenem resistant <i>Acinetobacter baumannii</i>

The effect of tigecycline-usnic acid combination on tigecycline-non-susceptible <i>Acinetobacter baumannii</i> clinical isolates and the role of usnic acid as an adjuvant efflux

<i>In vitro</i> activity of ceftazidime-avibactam in combination with aztreonam against carbapenem resistant <i>Enterobacterales</i> isolated from intensive care units

ANTIBIOTIC RESISTANCE OF ACINETOBACTER BAUMANNII: AN URGENT NEED FOR NEW THERAPY AND INFECTION CONTROL

Efficacy and Safety of Colistin for Treatment of Multidrug-Resistant Acinetobacter Baumannii

Evaluation of In vitro Activity of Cefiderocol and Ceftolozane-Tazobactam against Extended-Spectrum β-Lactamase–Producing Coliform and Multidrug Resistant Acinetobacter baumannii